Voisin Consulting Life Sciences publication icon
Publication

Regulatory Innovative Biomedical Products on Nanotechnology Requires a Combination of Drug and Device Evaluation Expertise

Post thumbnail Regulatory Innovative Biomedical Products on Nanotechnology Requires a Combination of Drug and Device Evaluation Expertise

Regulating innovative biomedical products based on nanotechnology requires a combination of drug and device evaluation expertise. Economic forecasts predict the market growth of nanotechnologies will reach hundreds of billion euros in the coming decade.

Voisin Consulting Life Sciences download icon

Download the full publication now

Fill in the form to download the content

    Yes, I would like to receive communications regarding VCLS services and events

    publication by

    Anne-Virginie Eggimann thumbnail
    Anne-Virginie Eggimann
    Executive Director
    Stuart Mudge thumbnail
    Stuart Mudge
    Senior Consultant Product Development